| |
|
|
|
ASLAN Pharmaceuticals Limited  
|
|
3.22 -0.18 (-0.05%) |
05-23 15:59 |
|
Open: |
3.4 |
Pre close: |
3.4 |
Target:
|
4.98
|
|
High: |
3.4 |
Low: |
3.4 |
Resistance:
|
4.27
4.80
|
|
Volume: |
2,834 |
Market Cap: |
104M |
Support:
|
3.40
2.83
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.44
 |
MACD |
MACD(12,26):
|
-0.15 |
|
MA(20): |
3.65 |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
3.79  |
Stochastic Oscillator |
%K(14,3):
|
0.96 |
|
MA(250): |
5.77 |
%D(3): |
2.49 |
|
Average Volume(K) |
3-Month: |
1059
|
52-Week |
High:
|
10.44 |
|
10-Days: |
375 |
Low: |
2.51 |
|
RSI |
RSI(14):
|
37.83 |
Change(%): |
-43.9 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-234.5 |
Shares Out. (M) |
32.05 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-161.4 |
Shares Float (M) |
32.05 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
11.50 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.870 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.88 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
6053889024.00 |
|
Operating Margin |
-1223.51 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
